Novelos Therapeutics Finalizes SPA with FDA for Phase 3 Trial in Lung Cancer (Business Wire via Yahoo! Finance)
NEWTON, Mass.----May 30, 2006--Novelos Therapeutics, Inc. , a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today announced that it has finalized a Special Protocol Assessment with the Food and Drug Administration for a single pivotal Phase 3 trial in advanced non-small cell lung cancer for its lead product NOV-002 in combination with first-line

WRAP 100 Receives US FDA Approval (PackagingNetwork)
Stanelco is pleased to announce that FDA compliance for its new material, Wrap 100, has now been confirmed by Pira International (the UK approved testing house for the FDA) for food contact approval

Stanelco plc (``Stanelco'' or ``the Company'') - WRAP 100 Receives US FDA Approval (Business Wire via Yahoo! Finance)
ORLANDO, Fla.----May 25, 2006--Stanelco is pleased to announce that FDA compliance for its new material, WRAP 100, made principally from sustainable resources, has now been confirmed by Pira International for food contact approval.